S'abonner

System-integrated technology-enabled model of care to improve the health of stroke patients in rural China: protocol for SINEMA—a cluster-randomized controlled trial - 14/12/18

Doi : 10.1016/j.ahj.2018.08.015 
Enying Gong, Msc a, b, Wanbing Gu, Msc a, Cheng Sun, PhD a, Elizabeth L. Turner, PhD c, d, Yun Zhou, MD e, Zixiao Li, MD,PhD e, Janet Prvu Bettger, ScD c, f, Brian Oldenburg, PhD b, Alba Amaya-Burns, MD,MSc a, Yilong Wang, MD,PhD e, Li-Qun Xu, PhD g, Jianmin Yao, MD h, Dejin Dong, BS i, Zhenli Xu, BS j, Chaoyun Li, PhD a, Mobai Hou, BS k, Lijing L. Yan, PhD,MPH a, c,
a Global Health Research Center, Duke Kunshan University, Jiangsu, China 
b School of Population and Global Health, The University of Melbourne, Victoria, Australia 
c Duke Global Health Institute, Duke University, North Carolina 
d Department of Biostatistics & Bioinformatics, Duke University, North Carolina 
e Beijing Tiantan Hospital, Capital Medical University, Beijing, China 
f Department of Orthopedic Surgery, Duke University, North Carolina 
g Center of Excellence for mHealth and Smart Healthcare, China Mobile Research Institute, Beijing, China 
h Nanhe County People Hospital, Hebei, China 
i Xingtai Center for Disease Control and Prevention, Hebei, China 
j Nanhe Center for Disease Control and Prevention, Hebei, China 
k Health Bureau of Nanhe County, Hebei, China 

Reprint requests: Lijing L. Yan, Duke Kunshan University, No. 8 Duke Avenue, Kunshan, Jiangsu, China, 215316.Duke Kunshan UniversityNo. 8 Duke AvenueKunshanJiangsu215316China

Abstract

Background

Despite the significant burden of stroke in rural China, secondary prevention of stroke is suboptimal. This study aims to develop a SINEMA for the secondary prevention of stroke in rural China and to evaluate the effectiveness of the model compared with usual care.

Methods

The SINEMA model is being implemented and evaluated through a 1-year cluster-randomized controlled trial in Nanhe County, Hebei Province in China. Fifty villages from 5 townships are randomized in a 1:1 ratio to either the intervention or the control arm (usual care) with a target to enroll 25 stroke survivors per village. Village doctors in the intervention arm (1) receive systematic cascade training by stroke specialists on clinical guidelines, essential medicines and behavior change; (2) conduct monthly follow-up visits with the support of a mobile phone application designed for this study; (3) participate in virtual group activities with other village doctors; 4) receive performance feedback and payment. Stroke survivors participate in a health education and project briefing session, receive monthly follow-up visits by village doctors and receive a voice message call daily as reminders for medication use and physical activities. Baseline and 1-year follow-up survey will be conducted in all villages by trained staff who are blinded of the randomized allocation of villages. The primary outcome will be systolic blood pressure and the secondary outcomes will include diastolic blood pressure, medication adherence, mobility, physical activity level and quality of life. Process and economic evaluation will also be conducted.

Discussion

This study is one of very few that aim to promote secondary prevention of stroke in resource-constrained settings and the first to incorporate mobile technologies for both healthcare providers and patients in China. The SINEMA model is innovative as it builds the capacity of primary healthcare workers in the rural area, uses mobile health technologies at the point of care, and addresses critical health needs for a vulnerable community-dwelling patient group. The findings of the study will provide translational evidence for other resource-constrained settings in developing strategies for the secondary prevention of stroke.

Le texte complet de cet article est disponible en PDF.

Plan


 Competing interests: The authors declare that they have no competing interests.
 Trial registration: The trial was registered with clinicaltrials.gov (NCT03185858).
 Deepak L. Bhatt, MD, MPH, served as guest editor for this article.
 RCT# NCT03185858


© 2018  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 207

P. 27-39 - janvier 2019 Retour au numéro
Article précédent Article précédent
  • Admission diagnoses among patients with heart failure: Variation by ACO performance on a measure of risk-standardized acute admission rates
  • Liliya Benchetrit, Chloe Zimmerman, Haikun Bao, Kumar Dharmarajan, Faseeha Altaf, Jeph Herrin, Zhenqiu Lin, Harlan M. Krumholz, Elizabeth E. Drye, Kasia J. Lipska, Erica S. Spatz
| Article suivant Article suivant
  • Blood pressure differences between home monitoring and daytime ambulatory values and their reproducibility in treated hypertensive stroke and TIA patients
  • William J. Davison, Phyo Kyaw Myint, Allan B. Clark, John F. Potter

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.